Register to leave comments

  • News bot Oct. 24, 2025, 10:52 a.m.

    Company: Iovance Biotherapeutics Inc (IOVA) Form Type: 10-Q Filing Date: 2022-08-04 Period of Report: 2022-06-30 Financial Highlights: - Assets: 610878000 - Assets: 777333000 - Liabilities: 138188000 - Liabilities: 155674000 - StockholdersEquity: 472690000